Crown Advisors Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-25,000
Closed -$3.55M 42
2024
Q2
$3.55M Buy
25,000
+10,000
+67% +$1.15M 2.28% 17
2024
Q1
$1.67M Hold
15,000
1.01% 34
2023
Q4
$1.95M Hold
15,000
1.33% 31
2023
Q3
$2.44M Hold
15,000
1.74% 24
2023
Q2
$2.75M Hold
15,000
1.79% 24
2023
Q1
$2M Buy
+15,000
New +$1.76M 1.49% 30

Other funds holding ACLS

Crown Advisors Management's ACLS Position: Q3 2024 in Review

Crown Advisors Management sold out of Axcelis (ACLS) in Q3 2024, closing a stake of 25,000 shares — an estimated $3.55M sold.

Crown Advisors Management first reported a position in ACLS in Q1 2023 and held it in 6 quarters. The position peaked at $3.55M in Q2 2024. 367 funds tracked by Wall St. Rank hold ACLS as of Q3 2024.

  • Crown Advisors Management reported no remaining Axcelis position as of Q3 2024 after selling out during the quarter.
  • Crown Advisors Management sold 25,000 Axcelis shares in Q3 2024, an estimated $3.55M.
  • Crown Advisors Management first reported a position in Axcelis in Q1 2023 and held it in 6 quarters.
  • Crown Advisors Management's Axcelis position peaked at $3.55M in Q2 2024.
  • 367 funds tracked by Wall St. Rank held Axcelis as of Q3 2024.

Based on Crown Advisors Management's 13F filing for Q3 2024, filed 12 Nov 2024.